http://www.unboundmedicine.com/medline/ebm/research/aldesleukinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19866543/full_citation/IL_2_immunotherapy_does_not_benefit_patients_taking_antiretrovirals_IL-2 immunotherapy does not benefit patients taking antiretrovirals. [News]
AIDS Patient Care STDS 2009 Mar; 23(3):221-2.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19828532/full_citation/Interleukin_2_therapy_in_patients_with_HIV_infection_Abrams D, Lévy Y, Losso MH, et al. 
Interleukin-2 therapy in patients with HIV infection. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Oct 15; 361(16):1548-59.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19731326/full_citation/Administration_of_high_dose_interleukin_2_in_a_2_year_old_with_metastatic_melanoma_Bernhardt MB, Hicks MJ, Pappo AS 
Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2009 Sep 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19729567/full_citation/Renal_cell_carcinoma_with_an_emphasis_on_drug_therapy_of_advanced_disease_part_2_Cersosimo RJ 
Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2. [Journal Article]
Am J Health Syst Pharm 2009 Sep 15; 66(18):1625-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19710436/full_citation/Renal_cell_carcinoma_with_an_emphasis_on_drug_therapy_of_advanced_disease_part_1_Cersosimo RJ 
Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 1. [Journal Article]
Am J Health Syst Pharm 2009 Sep 1; 66(17):1525-36.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19692326/full_citation/The_High_Dose_Aldesleukin__IL_2__"Select"_Trial:_A_Trial_Designed_to_Prospectively_Validate_Predictive_Models_of_Response_to_High_Dose_IL_2_Treatment_in_Patients_With_Metastatic_Renal_Cell_Carcinoma_Clement JM, McDermott DF 
The High-Dose Aldesleukin (IL-2) "Select" Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma. [JOURNAL ARTICLE]
Clin Genitourin Cancer 2009 Aug 1; 7(2):E7-E9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19622576/full_citation/Clinical_and_Immunologic_Effects_of_Intranodal_Autologous_Tumor_Lysate_Dendritic_Cell_Vaccine_with_Aldesleukin__Interleukin_2__and_IFN_{alpha}2a_Therapy_in_Metastatic_Renal_Cell_Carcinoma_Patients_Schwaab T, Schwarzer A, Wolf B, et al. 
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a Therapy in Metastatic Renal Cell Carcinoma Patients. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Jul 21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19621718/full_citation/Short_term_preoperative_IL_2_immunotherapy_in_operable_pancreatic_cancer:_a_randomized_study_Uggeri F, Caprotti R, De Grate L, et al. 
Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study. [Journal Article]
Hepatogastroenterology 2009 May-Jun; 56(91-92):861-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19343348/full_citation/Treatment_of_metastatic_renal_cell_carcinoma_Reeves DJ, Liu CY 
Treatment of metastatic renal cell carcinoma. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Apr 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18670745/full_citation/Interleukin_2_immunotherapy_action_on_innate_immunity_cells_in_peripheral_blood_and_tumoral_tissue_of_pancreatic_adenocarcinoma_patients_Degrate L, Nobili C, Franciosi C, et al. 
Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients. [JOURNAL ARTICLE]
Langenbecks Arch Surg 2008 Aug 1.
Abstract | Full Citation